Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.0278
-0.0026 (-8.55%)
At close: Oct 30, 2026
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $147.84 thousand as of November 10, 2026. It is the 51,085th most valuable company in the world and the 7,170th biggest in the United States. Its market cap has decreased by 95.15% in one year.
Market Cap
147.84K
Enterprise Value
2.88M
Revenue
n/a
Global Rank
Country Rank
#7,170 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 147.84K, a decrease of -99.78%. That is a compound annual growth rate of -63.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 147.84K | -94.61% |
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 260.99K |
| CERo Therapeutics Holdings | 258.13K |
| Regen BioPharma | 251.29K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 192.58K |
| Endonovo Therapeutics | 180.76K |
| THC Farmaceuticals | 163.18K |
| Sorrento Therapeutics | 163.11K |